Top Page
Audeara Ltd.
(Sydney:AUA)
Audeara Ltd. (AUA) vs. iShares MSCI Australia ETF (EWA)
Audeara Ltd. Business Overview & Revenue Model
Audeara Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.79M | 3.79M | 3.19M | 2.91M | 2.07M | 1.12M |
| Gross Profit | 1.36M | 1.36M | 943.12K | 1.14M | 946.11K | 510.33K |
| EBITDA | -2.90M | -2.90M | -2.75M | -3.80M | -3.07M | -1.08M |
| Net Income | -1.79M | -1.79M | -1.60M | -3.74M | -2.95M | -1.25M |
Balance Sheet | ||||||
| Total Assets | 4.30M | 4.30M | 4.89M | 4.73M | 5.49M | 6.57M |
| Cash, Cash Equivalents and Short-Term Investments | 1.42M | 1.42M | 1.27M | 2.62M | 2.87M | 5.74M |
| Total Debt | 1.12M | 1.12M | 112.18K | 210.74K | 275.11K | 67.60K |
| Total Liabilities | 3.01M | 3.01M | 3.28M | 1.57M | 1.41M | 665.76K |
| Stockholders Equity | 1.29M | 1.29M | 1.61M | 3.17M | 4.08M | 5.91M |
Cash Flow | ||||||
| Free Cash Flow | -1.95M | -1.95M | -1.34M | -2.98M | -3.78M | -1.11M |
| Operating Cash Flow | -1.81M | -1.81M | -1.33M | -2.97M | -3.58M | -1.08M |
| Investing Cash Flow | -149.02K | -149.02K | -8.47K | -16.00K | -229.26K | -23.71K |
| Financing Cash Flow | 2.08M | 2.08M | -10.88K | 2.74M | 939.73K | 7.10M |
Audeara Ltd. Technical Analysis
Audeara Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
51 Neutral | AU$6.15M | -2.68 | -123.13% | ― | 18.86% | -14.41% | |
48 Neutral | AU$5.77M | ― | -684.77% | ― | 8.64% | 33.88% | |
41 Neutral | AU$10.13M | ― | ― | ― | -51.64% | -21.74% | |
38 Underperform | AU$8.47M | -0.63 | -135.89% | ― | -21.60% | -657.00% | |
23 Underperform | AU$181.10M | -22.17 | ― | ― | -100.00% | 44.26% |
Audeara Ltd. Corporate Events
Audeara Limited has announced a change in the director’s interest, specifically regarding David Trimboli’s holdings. The change involves the acquisition of 954,763 ordinary fully paid shares and 1,250,000 unlisted options, which were issued as part of director fees and incentive options approved at the recent AGM. This adjustment in holdings reflects a strategic move to align director interests with company performance and shareholder value, potentially impacting the company’s governance and stakeholder confidence.
Audeara Limited announced a change in the director’s interest notice, specifically regarding Hsin-Chieh ‘Bill’ Peng. The change involves the acquisition of 1,500,000 unlisted options expiring on December 2, 2027, at an estimated value of $25,395. This acquisition was approved as incentive options at the company’s AGM, reflecting strategic moves in director-level holdings which may influence stakeholder perceptions and company operations.
Audeara Limited has issued 954,763 shares at an issue price of $0.028, following approval at the recent Annual General Meeting. This move aligns with the company’s compliance with relevant corporate regulations and indicates no undisclosed information that could affect investor assessments. The issuance is part of Audeara’s ongoing efforts to strengthen its market position and enhance shareholder value.
Audeara Ltd. announced the issuance of 4,250,000 unlisted options, set to expire on December 2, 2027, with an exercise price of $0.05. This move is part of previously announced transactions and reflects the company’s strategic efforts to enhance its financial flexibility and operational capabilities, potentially impacting its market positioning and stakeholder interests.
Audeara Limited has secured NMPA certification for its hearing personalisation technology in China, marking a significant regulatory and commercial milestone. This achievement enables the company to launch its product in China’s high-growth hearing aid market, enhancing its strategic partnership with Eastech and supporting its global licensing and commercial expansion strategy.
Audeara Limited has received $1.22 million from the Australian Government’s R&D Tax Incentive for the 2025 financial year, which has significantly benefited the company’s development of state-of-the-art headphones and personal sound amplification solutions. This funding has allowed Audeara to repay its R&D loan facility, extend its cash runway, and accelerate progress with international partners, ultimately supporting its technology roadmap and preserving shareholder value.
Audeara Limited held its Annual General Meeting, where all resolutions, including the special resolutions for the approval of the 7.1A Mandate and the renewal of Proportional Takeover Provisions, were passed. This outcome reflects strong shareholder support and may positively impact the company’s strategic direction and governance, reinforcing its market position in the hearing health industry.
Audeara Ltd. announced a proposed issue of securities, including 4,250,000 unlisted options and 954,763 ordinary fully paid shares, set to be issued on November 26, 2025. This move is part of the company’s strategic efforts to enhance its capital structure and potentially strengthen its market position, offering stakeholders an opportunity to engage with the company’s growth trajectory.
Audeara Ltd. has announced its Annual General Meeting (AGM) to be held on November 25, 2025, in Brisbane. The meeting will address several key resolutions, including the adoption of the Remuneration Report, the re-election of Mr. Hsin-Chieh (Bill) Peng as a Director, approval of a mandate to issue equity securities, and the issuance of shares to Mr. David Trimboli in lieu of director’s fees. Shareholders are encouraged to vote by proxy, and the outcomes of these resolutions could impact the company’s governance and financial strategies.
Audeara Ltd reported a significant increase in revenue for Q1 FY26, driven by its AUA Technology division and a substantial rise in Australian wholesale sales. The company secured a licensing agreement with Eastech to provide hearing technology for the Chinese market and expanded its international reach with a distribution agreement in Japan. These developments, along with a reduction in net cash outflows, position Audeara towards achieving cashflow breakeven and enhancing its global market presence.
Audeara Limited has secured its first purchase order for the Chinese hearing aid market through a licensing agreement with Eastech (Huizhou) Co., Ltd., marking a significant step in its global expansion. The order for 1,000 hearing aid technology license keys signifies initial commercial traction in China, a market with substantial growth potential due to its large population affected by hearing loss. The products will be sold under a third-party brand via leading Chinese e-commerce platforms, potentially reaching millions of consumers. This development underscores Audeara’s strategic entry into one of the largest healthcare markets, with future financial impacts dependent on market uptake and subsequent orders.
Audeara Limited has entered into a non-exclusive distribution agreement with Eyear System Inc., a Tokyo-based audiology and hearing solutions company, to introduce its Auracast™-enabled products in Japan. This partnership marks Audeara’s first international expansion of its new product suite, following successful implementations in Australia. The collaboration aims to accelerate the availability of Audeara’s products in Japan’s advanced hearing-health sector, with an initial order of 100 units and plans for joint exhibition at a major healthcare event. This move strengthens Audeara’s international presence and positions it as a key player in the global hearing technology market.
Audeara Limited has announced its Annual General Meeting (AGM) scheduled for November 25, 2025, in Brisbane, with a closing date for director nominations set for October 14, 2025. This meeting will provide an opportunity for stakeholders to engage with the company’s leadership and discuss future directions, potentially impacting Audeara’s strategic positioning in the hearing health industry.
Audeara Ltd. has announced the issuance of 4,200,000 unquoted options, set to expire on September 10, 2028, with an exercise price of $0.045. This move is part of an employee incentive scheme, indicating the company’s strategy to retain talent and motivate its workforce. The issuance of these securities could impact the company’s financial structure and is a signal of its commitment to growth and employee engagement.